TrialCarcinogenesis2013

The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.

Zhuo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.